DMPK, Radiolabelling, QWBA, Analytics, Bioanalysis, Immunogenicity, biomarker, API, chemical drug substance, formulation, clinical manufacturing, clinical trial supplies, QP services, Clinical Trial, Pharmacology Unit, Monitoring, Data Management, Biometrics, PK

Nuvisan, fully integrated CRO/CDMO, is offering all relevant GxP services from molecule synthesis up to early clinical trials for pharmaceutical and biotechnology industries. Assisting the client in bringing safe and effective products to the market, Nuvisan is well known for flexibility, strong employee loyalty, and high-quality level.
All possible options from a single test to full drug development programs:
– Non-Clinical Studies: InVitro & InVivo DMPK, Radiosynthesis, Metabolite profiling, QWBA ;
– Analytical Labs: Small and large molecule bioanalysis, Immunogenicity, Biomarkers ;
– Pharmaceutical Services: API synthesis, Formulation, Analytics, IMP manufacturing, Clinical Trial Supply, QP services ;
– Early Clinical Trials: In-house Pharmacology Unit, Clinical & Medical Monitoring, Data Management & Biometrics.